Loading data
Company
Merck & Co., Inc.
MRKNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 65.01 bn USD | 64.17 bn USD | 60.12 bn USD | 59.28 bn USD | 48.7 bn USD |
| Cost of revenue | 16.38 bn USD | 15.19 bn USD | 16.13 bn USD | 17.41 bn USD | 13.63 bn USD |
| Research and development expense | 15.79 bn USD | 17.94 bn USD | 30.53 bn USD | 13.55 bn USD | 12.25 bn USD |
| Selling, general and administrative expense | 10.73 bn USD | 10.82 bn USD | 10.5 bn USD | 10.04 bn USD | 9.63 bn USD |
| Interest expense | — | — | 1.15 bn USD | 962 m USD | 806 m USD |
| Profit before tax | 21.07 bn USD | 19.94 bn USD | 1.89 bn USD | 16.44 bn USD | 13.88 bn USD |
| Income tax expense | 2.8 bn USD | 2.8 bn USD | 1.51 bn USD | 1.92 bn USD | 1.52 bn USD |
| Net income (reported basis) | 18.25 bn USD | 17.12 bn USD | 365 m USD | 14.52 bn USD | 12.35 bn USD |
| Net income attributable to common shareholders | 18.25 bn USD | 17.12 bn USD | 365 m USD | 14.52 bn USD | 13.05 bn USD |
| Basic earnings per share | 7.3 USD/share | 6.76 USD/share | 0.14 USD/share | 5.73 USD/share | 5.16 USD/share |
| Diluted earnings per share | 7.28 USD/share | 6.74 USD/share | 0.14 USD/share | 5.71 USD/share | 5.14 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.